ArticleEnvironmental science and ecotechnology2026
Weighted network analysis of adverse outcome pathways decodes the multiscale mechanisms of environmental toxicity.
Article in Environmental science and ecotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- New approach methodologies for next-generation risk assessment of nanomaterials and nano-enabled products.Nano convergence · 2026Review
- Network toxicology and multi-omics identify potential interactions between between air pollutants and interferon-related signaling in tuberculosis.Molecular biology reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid proliferation of synthetic chemicals has significantly outpaced traditional toxicity characterization, leaving a critical data gap in environmental health risk assessment. While the adverse outcome pathway (AOP) framework provides a mechanistic scaffold for organizing toxicity knowledge, it is currently limited by a focus on linear pathways and a bias toward well-studied endpoints. Conversely, the exposome paradigm captures broad environmental stressors but often lacks the mechanistic depth required for causal interpretation. A fundamental challenge remains in developing integrative paradigms that can systematically bridge these multi-scale datasets to decode complex, chemical-induced diseases. Here we show that AOP-ExpoVis, an integrative computational platform, synergizes exposome-disease networks with AOP ontologies to prioritize pathogenic mechanisms through a weighted phenotype-disease scoring algorithm. By integrating chemical, gene, phenotype, and disease associations, the platform identifies key phenotypes and maps them to curated pathways to generate testable mechanistic hypotheses. Validation across three distinct case studies involving 2,2',4,4'-tetrabromodiphenyl ether (BDE-47), arsenic, and perfluoroalkyl substances (PFAS) demonstrated that AOP-ExpoVis accurately identifies both conserved and chemical-specific toxic pathways, such as aryl hydrocarbon receptor activation and lipid metabolism disruption. AOP-ExpoVis provides an open-source tool for rapid mechanistic inference that overcomes the limitations of traditional, single-pathway frameworks. This work advances predictive toxicology by enabling the systematic prioritization of chemical hazards and the refinement of regulatory risk assessment in a data-rich environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.